946
D. L. Wright et al. / Tetrahedron Letters 43 (2002) 943–946
Table 3. Sequential Passerini/IMDAF studies
Entry (MCR)a
R1
R2
MCR yield (%)
Entry (IMDAF)b
IMDAF yieldc (%)
14a
14b
14c
14d
14e
Me
Phd
Phd
Me
H
Bn
86
79
69
82
79
15a
15b
15c
15d
15e
77
72
68
72
tBu
tBu
tBu
Bn
Dec.
a Reactions were run at a concentration of 0.2 M in CH2Cl2 at rt.
b A 0.2 M solution of the furan in CH2Cl2 was treated with Me2AlCl at −78°C to rt.
c Yields reported are for a pure diastereomer.
d All MCRs with phenyl propiolic acid were run in the dark to limit alkyne dimerization.
This striking difference in reactivity is quite interesting
considering the small change from nitrogen to oxygen
in the tether. This difference in reactivity may reflect
the difference in conformation between an ester and
amide sidechain or in the stability of the cycloadducts.
Moreover, it was observed that the IMDAF derivatives
from the Passerini reaction were much less stable than
those derived from the Ugi products. The lactones
quickly undergo retro Diels–Alder reaction at elevated
temperatures while the lactams are completely stable.
This may explain the failure to effect IMDAF reaction
under thermal conditions with the acetylenic esters. An
even greater instability of the lactones was observed in
the presence of acid. For example, a solution of the
cycloadduct 15a prepared in commercial CDCl3 showed
reversion to the starting furan within hours at rt while
solutions in C6D6 are stable for at least one week.
Protic acids have been reported to promote retro-
IMDAF reactions of oxabicyclo[2.2.1]heptadiene
derivatives13 to regenerate furan starting materials. In
sharp contrast, the lactam derivatives do not show any
propensity to undergo cycloreversion upon exposure to
acidic conditions. Despite the structural similarities
present in these two families of oxabicyclo[2.2.1]-
heptadiene derivatives, their reactivities and stabilities
are quite different.
Battiste and Dr. Ion Ghiriviga are thanked for helpful
discussions.
References
1. (a) For wortmannin, see: MacMillan, J.; Vanstone, A. E.;
Yeboah, S. K. J. Chem. Soc., Perkin Trans. 1 1972, 2898;
(b) For viridin, see: Neidle, S.; Rogers, D.; Hursthouse,
M. B. J. Chem. Soc., Perkin Trans. 2 1972, 760.
2. Hazeki, O.; Hazeki, K.; Katada, T.; Ui, M. J. Lipid
Mediat. Cell Signal 1996, 14, 259.
3. Powis, G.; Berggren, M.; Gallegos, A.; Frew, T.; Hill, S.;
Kozikowski, A.; Bonjouklian, R.; Zalkow, L.; Abraham,
R.; Ashendel, C.; Schultz, R.; Merriman, R. Acta
Biochim. Pol. 1995, 42, 395.
4. Wymann, M. P.; BulgarelliLeva, G.; Zvelebil, M. J.;
Pirola, L.; Vanhaesebroeck, B.; Waterfield, M. D.;
Panayotou, G. Mol. Cell. Biol. 1996, 16, 1722.
5. Brunn, G. J.; Williams, J.; Sabers, C.; Wiederrecht, G.;
Lawrence, J. C.; Abraham, R. T. Embo J. 1996, 15, 5256.
6. Hartley, K. O.; Gell, D.; Smith, G. C. M.; Zhang, H.;
Divecha, N.; Connelly, M. A.; Admon, A.; Leesmiller, S.
P.; Anderson, C. W.; Jackson, S. P. Cell 1995, 82, 849.
7. For reviews, see: (a) Kappe, C. O.; Murphree, S. S.;
Padwa, A. Tetrahedron 1997, 53, 14179; (b) Padwa, A.;
Murphree, S. S. Org. Prep. Proc. Int. 1991, 23, 545.
8. (a) Ugi, I.; Domling, A.; Horl, W. Endeavour 1994, 3,
115; (b) Ugi, I.; Goebel, M.; Gruber, B.; Heilingbrunner,
M.; Heib, C.; Kern, O.; Starnecker, M. Res. Chem.
Intermed. 1996, 7, 625.
The sequential use of MCRs and cycloadditions can
lead to structurally complex materials in short
sequences. Utilizing Passerini and Ugi reactions in
tandem with an IMDAF led to annulated oxabicy-
clo[2.2.1]heptadiene derivatives that are amenable to
further elaboration. Studies on the conversion of the
Passerini derivatives to analogs of viridin is currently
under investigation.
9. (a) Paulvannan, K.; Jacobs, J. W. Tetrahedron 1999, 55,
7433; (b) Paulvannan, K. Tetrahedron Lett. 1999, 40,
1851.
10. Lee, D.; Sello, J. K.; Schreiber, S. L. Org. Lett. 2000, 5,
709.
11. Keay, B. A.; Rauk, A.; Hunt, I. R. J. Org. Chem. 1996,
61, 751.
12. All compounds were fully characterized by spectroscopic
methods. Molecular formula was determined by combus-
tion analysis or HRMS.
Acknowledgements
The authors would like to thank the American Cancer
Society (Florida Division) and the University of Flor-
ida for generous support of this work. Professor Merle
13. Maggiani, A.; Tubul, A.; Brun, P. Chem. Commun. 1999,
24, 2495.